Concepedia

miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis

Helen Hermann, Toomas Runnel, Alar Aab, Hansjörg Baurecht, Elke Rodríguez, Nathaniel Magilnick, Egon Urgard, Liisi Šahmatova, Ele Prans, Julia Maslovskaja,

Journal of Investigative Dermatology · 2017 · 90 citations · 31 references

DOIFull text

Open access

Concepts

References

31

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Konstantin D. Taganov, Mark Boldin, Kuang‐Jung Chang et al. · Proceedings of the National Academy of Sciences · 2006 · 4.3K citations · Full text

, , +17

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

, , +14

Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses

Li‐Fan Lu, Mark Boldin, Ashutosh Chaudhry et al. · Cell · 2010 · 1K citations · Full text

, , +13

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Kim Papp, Craig L. Leonardi, Alan Menter et al. · New England Journal of Medicine · 2012 · 929 citations

, , +17

<i>miR-146a</i> is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

Mark Boldin, Konstantin D. Taganov, Dinesh S. Rao et al. · The Journal of Experimental Medicine · 2011 · 867 citations · Full text

, , +17